Patent details

EP3476395 Title: INJECTABLE COMPOSITION COMPRISING FIBROBLASTS FOR USE IN THE TREATMENT OF HEART DISEASES

Basic Information

Publication number:
EP3476395
PCT Application Number:
JP2018006795
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP187584651
PCT Publication Number:
WO2018155651
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INJECTABLE COMPOSITION COMPRISING FIBROBLASTS FOR USE IN THE TREATMENT OF HEART DISEASES
French Title of Invention:
COMPOSITION INJECTABLE COMPRENANT DES FIBROBLASTES POUR SON UTILISATION DANS LE TRAITEMENT DE MALADIES CARDIAQUES
German Title of Invention:
INJIZIERBARE ZUSAMMENSETZUNG ENTHALTEND FIBROBLASTEN ZUR VERWENDUNG ZUR BEHANDLUNG VON HERZERKRANKUNGEN
SPC Number:

Dates

Filing date:
23/02/2018
Grant date:
21/07/2021
EP Publication Date:
01/05/2019
PCT Publication Date:
30/08/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/07/2021
EP B1 Publication Date:
21/07/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/02/2022
Expiration date:
23/02/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/07/2021
 
 

Name:
Metcela Inc.
Address:
5-22, Suehiromachi, Tsuruoka-shi, Yamagata 997-0015, Japan (JP)

Inventor

Name:
IWAMIYA, Takahiro
Address:
Japan (JP)

Priority

Priority Number:
2017033624
Priority Date:
24/02/2017
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 35/33; A61P 9/04; A61P 9/10; C12N 5/071;

Publication

European Patent Bulletin

Issue number:
202129
Publication date:
21/07/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages